Eli Lilly is a well-established pharmaceutical company with a portfolio of products that consistently generate revenue and ...

Conspiracies might be fun to entertain. But the "big lie" tactic destroys your judgment and credibility. Find out why, and ...

Why we procrastinate has less to do with willpower than with how flexibly our brains handle stress and discomfort - and the ...

One of the earliest mentions of New Year's resolutions appeared in a Boston newspaper in 1813. But the practice itself can be ...

We explain how aluminium went from a luxury metal to a world changing material. In the 1800s it was more expensive than gold. New refining methods dropped the price from $1.200 per kilo to just $1.

Abstract: Nowadays, as the demand for accurate object detection (OD) applications is increasing, several attempts have been made to introduce convolutional neural network (CNN)-based super-resolution ...

Nearly a third of US teenagers say they use AI chatbots daily, a new study finds, shedding light on how young people are embracing a technology that’s raised critical safety concerns around mental ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Thomas Anderson – otherwise known as Neo – is walking up a flight of stairs when he sees a black cat shake itself and walk past a doorway. Then the moment seems to replay before his eyes. Just a touch ...